Extraneal Peritoneal dialysis solution with 7.5% Icodextrin Dung dịch thẩm phân phúc mạc

Nazione: Vietnam

Lingua: vietnamita

Fonte: BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)

Principio attivo:

Icodextrin; Natri clorid ; Natri lactat ; Calci clorid.2H2O ; Magie clorid hexahydrat

Commercializzato da:

Baxter Healthcare (Asia) Pte., Ltd.

INN (Nome Internazionale):

Icodextrin; Sodium chloride ; Sodium lactate ; Calcium chloride.2H2O ; Magnesium chloride hexahydrate

Dosaggio:

7,5 mg; 538 mg; 448 mg; 25,7 mg; 5,08 mg

Forma farmaceutica:

Dung dịch thẩm phân phúc mạc

Confezione:

Túi nhựa 2 lít

Classe:

Thuốc kê đơn

Prodotto da:

Baxter HealthCare SA, Singapore branch

Dettagli prodotto:

Tiêu Chuẩn: NSX; Tuổi Thọ: 24 tháng

Foglio illustrativo

46J2o
=
(4/20)
BỘ
Y
TẾ
CUC
QUAN
LY
DUOC
MGDbMMVW
ĐÃ
PHÊ
DUYỆT
Me
tI^8
a4)
FN
B
49
8
4
Lan
daub.)
9.)
ld
(
soo
as
Baxter
a
(27
ou
oe
EXTRANEAL
Peritoneal
Dialysis
Solution
with
7.
5%
——
WT
EACH
100
mL
CONTAINS
7.5
g
ICODEXTRIN
S38
mg
SODIUM
CHLORIDE
USP
448
mg
SODIUM
LACTATE
25.7
mg
CALCIUM
CHLORIDE
USP
5.08
mg
MAGNESIUM
CHLORIDE
USP
pH
5.2
6.0
TO
6.0)
3
mmol/L
SODIUM132
CALCIUM1.75
MAGNESIUM0.25
GHLORIDE
96
LACTATE
40
=
—=—
OSMOLARITY
284
mOsmol/L
(CALC)
`?
h
STERILE
NONPYROGENIG
STORE
BELOW
30°G
SEE
INSERT
FOR
INTRAPERITONEAL
ADMINISTRATION
ONLY
NOT FOR
INTRAVENOUS
USE
CAUTIONS
SQUEEZE
AND
INSPECT
INNER
BAG
WHICH
MAINTAINS
PRODUCT
STERILITY
DISCARD
IF
LEAKS
ARE
FOUND
DO
NOT USE
UNLESS
SOLUTION
IS
CLEAR
DISCARD
UNUSED
PORTION
KEEP
OUT
OF
REACH
OF
CHILDREN
MANUFACTURED
BY
BAXTER
HEALTHCARE
SA,
SINGAPORE
BRANCH
ULTRABAG
CONTAINER
PL-146
2
WOODLANDS
INDUSTRIAL
PARK
D
STREET
2
SINGAPORE
737778
SIN11220P
HK-46627
MAL06021264X
(AN
AFFILIATE
OF
BAXTER
HEALTHCARE
CORPORATION
USA)
DIRECTION
TO
BE
USED
AS
DIRECTED
BY
PHYSICIAN
an
fan
fF
DSi
30
BILE
JAUHI
DARIPADA
KANAK
KANAK
RGR
:
FRR
BETA
THAI
REG.
NO.
2C
16/51
(NC)
‘aN
SZERERBTR
nmuANA
Visa
No.:xxxx
lậi
3
St
5
023687
Đš
2iEFl5SRI16
1
Ht
Sie
Be
RT
MARR
SF
OD
Ð.šffr7
an
at
bolas
BA
BSSRZaRAARAA
83trh31LFR&@2EX2163%
SHE
9|
^
EPLel
9l
5998/5853
WAS
KE
1000mi
S
ool
BAA
Ze
(AF)
75.09
SSE
(EP)5.a8g
SIAL}
HW
(60.0%)
(USP)
7.5g
(SAH
BHO@A
4.489)
SRHIG
(EP)0.257g
Selous
(EP)
0.0508g
(SUBSOBA
3.045mo/m
SZSOBRA
0.069mg/ml
BATH
OBA
0.006maiml
`
Sesh
3.41
Smg/ml
ŠNdS
=4
3.577mg/ml)
SW
ADL
UY
ASA
AE,
S35]
SRBAMOl
ha]
ROU}
S|
Aro]
zB
ell
SAtSACAPpD)
se
XLSS+8}#2I(APD)
A|S.s[
URBOLBA
BASS]
CAPD
4|BAZHS
ASS]
MRoll
sHzol
13
tts]
faa
Dee
Walses
AUszict.
MAK
AHS
VUotol
FAR
ORA
OO
MYAEA
75%S
HRI
Gt
Sapsaoom
Satitolar
EQS
pt
Boo]
BAUcilol]
#0{s‡g]
sHiirt.
S2)
Sz|@5tt|gl
821900
8214111,
BY
Bl
Bet
SULA
Aloe
ZA:
2000
ml/H
X|ãƑEHH:
8lE37|,
30°G
o]stolAl
Hat
HEH
S
/ALBIISE
WE
#A|
N
AjZz:
Baxter
Healthcare
SA,
Singapore
Branch,
2
Woodlands
Industrial
Park
D
Street
2,